Angiotensin II (Ang II) induces transactivation of the epidermal growth factor (EGF) receptor (EGF-R), which serves as a scaffold for various signaling molecules in vascular smooth muscle cells (VSMCs). Cholesterol and sphingomyelin-enriched lipid rafts are plasma membrane microdomains that concentrate various signaling molecules. Caveolae are specialized lipid rafts that are organized by the cholesterol-binding protein, caveolin, and have been shown to be associated with EGF-Rs. Angiotensin II stimulation promotes a rapid movement of AT 1 receptors to caveolae; however, their functional role in angiotensin II signaling has not been elucidated. Here we show that cholesterol depletion by ␤-cyclodextrin disrupts caveolae structure and concomitantly inhibits tyrosine phosphorylation of the EGF-R and subsequent activation of protein kinase B (PKB)/Akt induced by angiotensin II. Similar inhibitory effects were obtained with other cholesterol-binding agents, filipin and nystatin. In contrast, EGF-R autophosphorylation and activation of Akt/PKB in response to EGF are not affected by cholesterol depletion. The early Ang II-induced upstream signaling events responsible for transactivation of the EGF-R, such as the intracellular Ca 2؉ increase and c-Src activation, also remain intact. The EGF-R initially binds caveolin, but these two proteins rapidly dissociate following angiotensin II stimulation during the time when EGF-R transactivation is observed. The activated EGF-R is localized in focal adhesions together with tyrosinephosphorylated caveolin. These findings suggest that 1) a scaffolding role of caveolin is essential for EGF-R transactivation by angiotensin II and 2) cholesterol-rich microdomains as well as focal adhesions are important signal-organizing compartments required for the spatial and temporal organization of angiotensin II signaling in VSMCs.
Angiotensin II (Ang II) 1 is a highly pluripotential hormone in vascular smooth muscle cells (VSMCs) and stimulates multiple signaling pathways, including Src family kinases, as well as mitogen-activated protein kinases (MAPKs) and Akt/protein kinase B (PKB), that mediate VSMC hypertrophy and growth via AT 1 receptors (AT 1 Rs). Increasing evidence suggests that transmodulation of the epidermal growth factor receptor (EGF-R), which serves as a scaffold for various signaling molecules, plays an essential role in organizing Ang II-mediated tyrosine kinase signaling pathways. We and others (1, 2) have demonstrated that EGF-R transactivation by Ang II is mediated through Ca 2ϩ , c-Src, and NADPH oxidase-derived reactive oxygen species, leading to activation of downstream signaling such as extracellular signal regulated kinase (ERK) and Akt/ PKB in VSMCs.
Relatively little is known of the mechanisms controlling the spatial and temporal organization of AT 1 R signaling in VSMCs or of how specificity is achieved. We showed originally that Ang II signaling in VSMC is biphasic and that internalization or sequestration of the agonist-occupied receptor into a "signaling domain" is required for the development of the tonic phase of signaling but not for the initial phospholipase C activation (3) . Evidence suggests that to direct a coordinated cascade that provides a specific and efficient signal to the cells, receptors and the signaling molecules with which they associate are not randomly distributed in the cell membrane but must be compartmentalized into specialized microdomains.
Lipid rafts are identified as plasma membrane microdomains that concentrate various signaling molecules. Caveolae are a specialized form of lipid rafts that appear as flask-shaped invaginations of 50-to 100-nm diameter in the plasma membrane (4) . Although they were originally implicated in cellular transport processes, recent evidence suggests that they may participate in signal transduction-related events as well (4) . Relative to the rest of the plasma membrane, caveolae membrane fractions are enriched in Src-family kinases, the EGF-R and platelet-derived growth factor receptor, suggesting that caveolae are involved in cellular signaling (4) . We have previously demonstrated that Ang II stimulates movement of AT 1 Rs into a caveolin-enriched membrane fraction in VSMCs (5) , suggesting that caveolae-like microdomains might serve to coordinate complex Ang II-mediated signaling. Lipid rafts and caveolae contain high concentrations of cholesterol and sphingolipids, and thus the cholesterol content of caveolae contributes to the integrity of caveolae structure and its functional importance in signaling. Depletion of cholesterol from the plasma membrane has been shown to inhibit insulin stimulation of glucose transport and metabolic protein phosphorylation in rat adipocytes (6, 7) , as well as ERK activation by endothe-lin-1, shear stress, and nerve growth factor in primary astrocytes, cultured endothelial cells, and PC12 cells, respectively (8 -10) .
The function of caveolae is also dependent on the scaffolding attributes of caveolin. Caveolin-1 is a 21-to 24-kDa integral membrane protein that acts as the coat protein of caveolae (4) . Interestingly, the caveolin-1 scaffolding domain (residues 82-101) can interact directly with receptor tyrosine kinases such as EGF-Rs and platelet-derived growth factor receptors and various signaling molecules through a common motif found within these proteins (4) . These interactions are believed to sequester the proteins within caveolae and to modulate or suppress their catalytic activities (4) . Of note, the AT 1 R has a consensus binding site for interaction with caveolin and, in fact, coprecipitates with caveolin (5), indicating that caveolin may serve as a docking site to spatially and temporally organize signaling molecules in AT 1 R signaling.
An additional potential level of control of signal transduction in caveolae is the tyrosine phosphorylation of caveolin. Caveolin-1 was first identified as a major tyrosine-phosphorylated protein in v-Src-transformed chicken embryo fibroblasts (11) , and has recently been shown to be phosphorylated on tyrosine 14 by growth factors, including EGF and insulin, as well as by cellular stress such as high osmolarity, H 2 O 2 , and UV light, in a c-Src-dependent manner (12) . Although the functional importance of this phosphorylation is unknown, tyrosine-phosphorylated caveolin has been suggested to provide a docking site for SH2-containing molecules and to serve as a positive regulator of cell signaling through its specific localization in focal adhesions, a major site of tyrosine kinase signaling in vivo (12) . Of note, focal adhesions may be another candidate "signaling domain" on the plasma membrane where spatial and/or temporal compartmentalization of signaling complexes can be achieved. The focal adhesion complex is a highly organized site at which the actin cytoskeleton attaches indirectly, through the proteins vinculin, paxillin, and talin, to aggregates of transmembrane heterodimeric ␣-and ␤-integrins (13) . It has been shown that the activated AT 1 R stimulates focal adhesion complex formation and cytoskeletal reorganization (14) .
Based on the observations that Ang II signaling occurs in specialized domains (3) , and that the EGF-R functionally associates with caveolae/caveolin, we tested the hypothesis that caveolae may play a role in EGF-R transactivation by Ang II in VSMCs. For this purpose, we examined the effects of plasma membrane cholesterol depletion on EGF-R transactivation and of Ang II on caveolin phosphorylation. We found that EGF-Rmediated signaling induced by Ang II, but not by EGF, is inhibited by cholesterol depletion. In addition, Ang II phosphorylates caveolin on tyrosine 14 in focal adhesions where activated EGF-Rs are localized. These findings strongly suggest that cholesterol-rich microdomains as well as focal adhesions are essential signal-organizing compartments for EGF-R transactivation and provide insight into the mechanisms controlling the spatial and temporal organization of complex AT 1 R signaling in VSMCs.
EXPERIMENTAL PROCEDURES
Materials-Anti-caveolin-1 monoclonal antibody (2297), anti-phospho-caveolin-1 monoclonal antibody (pY14, clone 56), and horseradish peroxidase-conjugated anti-phosphotyrosine antibody (RC20) were obtained from BD Transduction Laboratories, Inc. Anti-EGF receptor polyclonal antibody (1005) and protein A-G-agarose were from Santa Cruz Biotechnology. Rabbit polyclonal antibodies for anti-Akt/PKB and anti-phospho-Akt/PKB (pS473) were purchased from Cell Signaling. Human recombinant EGF and mouse monoclonal anti-c-Src antibody were from Upstate Biotechnology Inc. Rabbit polyclonal antibodies for anti-phospho-c-Src (pY418), anti-phospho-EGF-R (pY845), and antiphospho-paxillin (pY31) were obtained from BIOSOURCE International. These affinity-purified rabbit polyclonal antibodies are highly selective for the targeted phosphorylation site, as demonstrated by peptide competition studies and/or by analyzing site-directed ( Cell Culture-VSMCs were isolated from male Sprague-Dawley rat thoracic aortas by enzymatic digestion as described previously (15) . Cells were grown in DMEM supplemented with 10% calf serum, 2 mM glutamine, 100 units/ml penicillin, and 100 g/ml streptomycin and were passaged twice a week by harvesting with trypsin:EDTA and seeding into 75-cm 2 flasks. For experiments, cells between passages 6 and 15 were used at confluence.
Immunoprecipitation and Immunoblotting-Growth-arrested VSMCs were stimulated with agonist at 37°C, and cells were lysed with 500 l of ice-cold lysis buffer, pH 7.4 ((in mM) 50 HEPES, 5 EDTA, 50 NaCl), 1% Triton X-100, protease inhibitors (10 g/ml aprotinin, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml leupeptin) and phosphatase inhibitors ((in mM) 50 sodium fluoride, 1 sodium orthovanadate, 10 sodium pyrophosphate). For immunoprecipitation, cell lysates (600 g) were immunoprecipitated with antibody overnight at 4°C and then incubated with 25 l of protein A-G-agarose beads for 1.5 h at 4°C. Cell lysates (25 g) or immunoprecipitates were separated using SDSpolyacrylamide gel electrophoresis and transferred to nitrocellulose membranes, blocked overnight in PBS containing 6% nonfat dry milk and 0.1% Tween 20, and incubated for 1 h with primary antibodies as described previously (16) . After incubation with secondary antibodies, proteins were detected by ECL chemiluminescence.
Measurements of Intracellular Calcium Concentration-Growth-arrested VSMCs were loaded with Fura-2 AM (10 M) for 45 min, washed, and equilibrated in balanced salt solution ((in mM) 130 NaCl, 5 KCl, 1 MgCl 2 , 1.5 CaCl 2 , 20 HEPES (buffered to pH 7.4 with Tris base)). Cells were stimulated with 100 nM Ang II and fluorescence of 5-10 adjacent cells was monitored at 520 (Ϯ20 nm) when alternately excited with 340-and 380-nm light (at 100 Hz) with a high time resolution microfluorimeter as described previously (17) .
Immunofluorescence-VSMCs were plated onto 22-mm diameter round glass coverslips in six-well clusters. Following treatment with 100 nM Ang II, cells were rinsed quickly in ice-cold PBS, fixed in freshly prepared 4% paraformaldehyde in PBS for 10 min at room temperature, permeabilized in 0.05% Triton X-100 in PBS for 5 min, and rinsed sequentially in PBS, 50 mM NH 4 Cl, and PBS for 10 min each. After an incubation for 1 h in blocking buffer (3% bovine serum albumin in PBS), the cells were incubated with primary antibodies for 1 h, rinsed in PBS/bovine serum albumin, and then incubated for 1 h with the appropriate species-specific secondary antibodies conjugated to either FITC or Rhodamine Red X. Controls consisted of omission of primary antibody. Cells on coverslips were mounted onto glass slides in Vectashield and examined with either a Bio-Rad MRC 1024, using argon laser excitation lines of 488 and 514 nm with emission filters of 540/30 and 580/32 nm, or a Zeiss 510 LSCM system, using argon and green helium/ neon laser excitation lines of 488 and 543 nm with emission filters of BP 500 -550 and LP 560. Negligible bleed-through was confirmed in duallabeling experiments by imaging single-labeled specimens.
Transmission Electron Microscopy-VSMCs were plated at 8 ϫ 10 4 cells/ml onto 35-mm tissue culture dishes and grown for 48 h in DMEM supplemented with 10% calf serum and antibiotics. Cells were serumstarved for 18 h, treated with 10 mM ␤-cyclodextrin in serum-free DMEM for 1-2 h at 37°C, rinsed in cold PBS, and fixed in 1% glutaraldehyde in 0.1 M sodium cacodylate buffer. Following postfixation in 1% osmium tetroxide ϩ 1.5% potassium ferrocyanide in 0.1 M cacodylate buffer, cells were dehydrated in a graded alcohol series and embedded in Epon-812 resin. Sections were taken perpendicular to the substrate and stained with uranyl acetate and lead citrate. Images taken on a Hitachi H-7500 electron microscope operated at 60 kV were digitized and imported into Adobe PhotoShop 5.5 for presentation. Ultrathin sections, analyzed with IMAGE software (National Institutes of Health), were used to count the number of caveolae per micron of membrane in 10 -16 fields containing profiles of 17 or 18 independent cells from control and ␤-cyclodextrin-treated VSMCs, respectively. Caveolae were defined as uncoated 50-to 100-nm surface invaginations with clear connections to the plasma membrane.
Measurement of Cholesterol Using the Incorporation of [
14 C]AcetateGrowth-arrested VSMCs grown in 100-mm culture dishes were labeled for 24 h with 0.5 Ci of [ bated in 6 ml of serum-free medium with or without 10 mM ␤-cyclodextrin for 2 h. At the end of the incubation, the medium was collected and then saponified using equal volumes of 1 N NaOH and ethanol and heated for 1 h at 60°C. After saponification, the lipids were extracted with 2 ml of hexane. The hexane was evaporated under nitrogen and radioactivity was then quantified by a ␤-counter as described previously (18) .
Measurement of Cholesterol Content in the Plasma Membrane Fraction-Growth-arrested
VSMCs grown in 100-mm culture dishes were treated with or without 10 mM ␤-cyclodextrin for 2 h. At the end of the incubation, the cells were washed and scraped into 10% 0.25 M sucrose (pH 7.4). The cells were homogenized and centrifuged serially at 109 ϫ g, 1720 ϫ g, and 28,000 ϫ g. The plasma membrane fraction was collected and suspended in a minimum amount of PBS. An aliquot was used for protein estimation. The rest of the pellet (1 ml) was extracted with 2:1 methanol:chloroform, followed by 0.5 ml of chloroform. The chloroform (lipid phase) was separated and evaporated under nitrogen. The dry lipid was suspended in 2-propanol, and the membrane cholesterol was assayed using the Sigma Infinity cholesterol reagent per the manufacturer's instructions.
Statistical Analysis-Results are expressed as mean Ϯ S.E. Statistical significance was assessed by Student's paired two-tailed t test or analysis of variance on untransformed data, followed by comparison of group averages by contrast analysis, using the SuperANOVA statistical program (Abacus Concepts, Berkeley, CA). A p value of Ͻ0.05 was considered to be statistically significant.
RESULTS

Effect of ␤-Cyclodextrin on Cholesterol Content and Caveolae
Structure in Plasma Membranes of VSMCs-It has been demonstrated that caveolae-like structures can be disrupted by cholesterol depletion using ␤-cyclodextrin (7, 9) . To confirm this observation in VSMCs, we examined the effects of ␤-cyclodextrin on cholesterol efflux into the extracellular medium and on cholesterol content of the plasma membrane fraction. As shown in Fig. 1, A and B, 10 mM ␤-cyclodextrin treatment dramatically enhanced the cholesterol efflux and reduced the cholesterol content of the plasma membrane by about 50%, indicating that ␤-cyclodextrin efficiently depletes plasma membrane cholesterol in VSMCs. Under these conditions, the structural integrity of caveolae in the plasma membrane was almost completely disrupted, as revealed by transmission electron microscopy showing the disappearance of caveolae invaginations at the membrane surface after ␤-cyclodextrin treatment (Fig. 1C) . Although caveolar profiles were clearly visible in control cells (41 caveolae/920-m membrane), there were no morphologically recognizable caveolae in any membrane profiles examined after cholesterol depletion with ␤-cyclodextrin. At the ultrastructural level, the general morphology of ␤-cyclodextrin-treated cells was similar to control cells. At the light microscopic level, 14% of the cells were rounded and retracted after 2 h of 10 mM ␤-cyclodextrin treatment (data not shown).
Effect of Cholesterol Depletion on EGF-R Phosphorylation by Ang II and EGF-We have previously demonstrated that upon
Ang II binding to the AT 1 receptor, the agonist-receptor complex moves to caveolae-enriched membrane fractions and that the AT 1 receptor and caveolin coimmunoprecipitate (5) . Because EGF-Rs are also localized to caveolae and associated with caveolin, we hypothesized that caveolae may play a role in EGF-R transactivation. As shown in Fig. 2A , depletion of cholesterol by 10 mM ␤-cyclodextrin almost completely inhibited tyrosine phosphorylation of the EGF-R by Ang II. This inhibitory effect of ␤-cyclodextrin was dose-dependent (41 Ϯ 4% inhibition (n ϭ 3) at 5 mM and 95 Ϯ 8% inhibition (n ϭ 3) at 10 mM) and was prevented if cholesterol was added back to the incubation medium during the ␤-cyclodextrin treatment. Importantly, the higher concentrations of ␤-cyclodextrin had no effect on cell viability as determined by trypan blue exclusion. Similar inhibitory effects on EGF-R phosphorylation were obtained by two other cholesterol binding agents, filipin and nystatin ( Fig. 2A) . In contrast, ␤-cyclodextrin treatment enhanced, rather than inhibited, EGF-induced EGF-R autophosphorylation (Fig. 2B) .
We next examined the effects of Ang II and EGF on Akt/PKB, a major downstream target of the EGF-R. As shown in Fig. 3,   FIG. 1 . Effects of ␤-cyclodextrin on plasma membrane cholesterol levels and caveolae structure in VSMCs. A, effect of ␤-cyclodextrin on cholesterol efflux into the extracellular medium. VSMCs were prelabeled with [
14 C]acetate for 24 h, washed, and then treated with or without 10 mM ␤-cyclodextrin for 2 h. The radioactivity of 14 C-labeled cholesterol in the media was quantified as a measure of cholesterol efflux. Experiments were performed in triplicate. Data are expressed as dpm/dish. The amount of protein per dish is ϳ2 mg/ml. B, effect of ␤-cyclodextrin on cholesterol content in the plasma membrane fraction: VSMCs were treated with or without 10 mM ␤-cyclodextrin for 2 h, washed, and then the plasma membrane fraction was isolated (see "Experimental Procedures"). The amount of cholesterol in the membrane fraction was measured by using the Sigma Infinity cholesterol reagent. Triplicate dishes of cells were used for each experiment. Data are expressed as the amount of cholesterol (g/mg protein). *, p Ͻ 0.05 versus control. C, effect of ␤-cyclodextrin on caveolae structure in VSMC plasma membranes. VSMCs incubated without (a) or with (b) 10 mM ␤-cyclodextrin for 2 h were prepared for transmission electron microscopy. Ultrathin sections were prepared to count the number of caveolae per micron of membrane in 10 -16 fields containing profiles of 17 or 18 independent cells from control and ␤-cyclodextrin-treated VSMCs, respectively. Caveolae were defined as uncoated 50-to 100-nm surface invaginations with clear connections to the plasma membrane. In contrast to the plasma membrane of control cells showing typical flaskshaped caveolae (arrows) (a), caveolar structure is lost in ␤-cyclodextrin-treated cells (b). Bar ϭ 200 nm.
in parallel to the effect on EGF-R phosphorylation, the depletion of cholesterol by ␤-cyclodextrin significantly inhibited Akt/ PKB phosphorylation by Ang II in a dose-dependent manner but had no effect on the EGF-induced response. Similar inhibitory effects were obtained by two other cholesterol binding agents, filipin or nystatin (data not shown). Thus, a cholesterolrich microdomain is important for Ang II-stimulated signaling linked to the activation of EGF-R and its downstream target, Akt/PKB. (20) . ␤-Cyclodextrin had no effect on either phase of the Ca 2ϩ response (data not shown). This is consistent with our previous observation that phospholipase C activation is independent of any requirement for receptor sequestration or compartmentalization (3). In addition, Ang IIinduced activation of c-Src, as detected by an antibody specific for activated phospho-c-Src (pY418), was unaffected by ␤-cyclodextrin and nystatin treatments (data not shown). These data suggest that the importance of cholesterol-rich microdomains in EGF-R transactivation by Ang II does not involve these early, upstream signaling molecules.
Lack of Effect of Cholesterol Depletion on Upstream Signaling Pathways Linked to EGF-R Transactivation-Several
Effect of Ang II on EGF-R-Caveolin Interactions and on Tyrosine Phosphorylation of
Caveolin-Because cholesterol depletion affects lipid rafts as well as caveolae, we tried to focus more on the role of caveolae/caveolin in EGF-R transactivation. A major mechanism by which caveolae appear to contribute to cellular function involves the scaffolding ability of caveolin-1. Binding to caveolin usually maintains signaling molecules in an inactive state, and the EGF-R has been shown to associate with caveolin (21) . Therefore, we hypothesized that transactivation of the EGF-R by Ang II would be associated with release from caveolin. We thus examined whether Ang II stimulation modulates the interaction between EGF-R and caveolin-1. EGF-Rs were immunoprecipitated with anti-EGF-R antibody, and precipitates were separated by SDS-polyacrylamide gel electrophoresis and blotted with a monoclonal caveolin antibody. As shown in Fig. 4A , caveolin and EGF-Rs coimmunoprecipitated in unstimulated cells. However, these proteins rapidly dissociated within 1 min of Ang II stimulation during the time when EGF-R transactivation was observed. Interestingly, EGF-R and caveolin gradually re-associated with each other until their interaction was equivalent to pre-stimulation levels at 60 min. The time course of dissociation was cotemporaneous with Ang II-induced tyrosine phosphorylation of caveolin, as detected by a monoclonal caveolin antibody specifically recognizing tyrosine 14-phosphorylated caveolin-1. As shown in Fig.  4B , tyrosine phosphorylation of caveolin by Ang II occurred within 1 min, peaked at 15 min (2.1 Ϯ 0.4-fold increase, p Ͻ 0.05) and gradually decreased to basal levels by 60 min. Total caveolin-1 expression did not change during Ang II stimulation, suggesting that Ang II specifically modulates phosphorylation of caveolin. This Ang II-induced tyrosine phosphorylation of caveolin was completely inhibited by the Src family kinase inhibitor PP1 (10 M) (data not shown). These data suggest that Ang II stimulates rapid dissociation of EGF-Rs from caveolin, which is temporally associated with an increase in c-Src-dependent tyrosine phosphorylation of caveolin. Of note, we found that only a fraction of cellular caveolin is associated
FIG. 2. Effect of cholesterol-binding agents on EGF-R phosphorylation by Ang II and EGF in VSMCs.
A, VSMCs were preincubated with or without 1 or 2 g/ml filipin for 15 min, 5 or 10 g/ml nystatin for 15 min, or 10 mM ␤-cyclodextrin without or with 16 g/ml cholesterol for 1 h and then stimulated with (ϩ) or without (Ϫ) 100 nM Ang II for 1.5 min. B, VSMCs were preincubated with or without 10 mM ␤-cyclodextrin for 1 h and then stimulated with (ϩ) or without (Ϫ) 100 ng/ml EGF for 30 s. Lysates were immunoprecipitated with anti-EGF-R antibody, followed by immunoblotting with phosphotyrosine (pTyr) antibody (top panel) or EGF-R antibody (middle panel). The bottom panel represents averaged data, corrected for total EGF-R loading, expressed as -fold change over basal (the ratio in untreated cells was set to 1). Values are the means Ϯ S.E. for three independent experiments. *, p Ͻ 0.05 for increase in phosphorylation by Ang II (A) or EGF (B) in the presence of inhibitor versus Ang II or EGF alone. with EGF-Rs in basal state (ϳ6%) and a similar portion (ϳ8%) is tyrosine-phosphorylated in Ang II-stimulated VSMCs.
Role of Focal Adhesions in EGF-R Transactivation-To determine whether transactivated EGF-R and tyrosine-phosphorylated caveolin-1 are spatially associated, we next examined their subcellular localization. Because Ang II-induced EGF-R transactivation is dependent on c-Src (2, 19), we stained VSMCs with a rabbit polyclonal antibody against the c-Srcspecific phosphorylation site of the EGF-R (pY845) as a measure of transactivated EGF-R before and after stimulation with Ang II. As shown in Fig. 5A , upon addition of Ang II, phosphorylated EGF-Rs showed intense localization at insertion sites of the actin cytoskeleton, similar to the distribution of focal adhesions. To confirm this possibility, we stained the same sections with an antibody against vinculin, an integral protein of focal adhesions (13) . As shown in Fig. 5A , activated EGF-Rs colocalized with vinculin, suggesting that EGF-Rs may be transactivated at focal adhesions upon release from caveolin. Of importance, tyrosine 14-phosphorylated caveolin colocalized with the focal adhesion protein paxillin (Fig. 5B) and the transactivated EGF-R (Fig. 5C ), indicating that these molecules are all colocalized in focal adhesions. Importantly, both phosphorylated EGF-Rs and paxillin coprecipitated with phosphocaveolin (data not shown), suggesting formation of an active signaling complex with these molecules in these specific signaling domains. In contrast, immunostaining with anti-caveolin-1 antibody showed little or no colocalization with paxillin (results not shown). Rather, caveolin staining was punctate in patches over the cell surface, along the cell margins, and concentrated in the nuclear area, suggesting that tyrosine-phosphorylated caveolin is localized in a different region of the cell (focal adhesion) and that only a subfraction of caveolin is tyrosinephosphorylated (12) . DISCUSSION EGF-R transactivation is centrally important in organizing tyrosine kinase signaling by Ang II in VSMCs (22, 23) . Because the EGF-R has been shown to be associated with caveolae/ caveolin (21), we examined the role of caveolae-like membrane domains in Ang II-induced transactivation of EGF-R. Here we provide evidence that cholesterol depletion, which disrupts caveolae structure, inhibits tyrosine phosphorylation of the EGF-R and subsequent Akt/PKB activation induced by Ang II but not by EGF. In contrast, the early upstream signaling events such as increased intracellular Ca 2ϩ and c-Src activation remain intact. The EGF-R initially binds caveolin, but upon stimulation with Ang II, this association is disrupted. The transactivated EGF-R is localized in focal adhesions together with tyrosine-phosphorylated caveolin. These findings suggest that cholesterol-rich microdomains as well as focal adhesions are important signal-organizing compartments required for EGF-R transactivation. Importantly, Ang II-modulated interaction of EGF-R with caveolin implicates the specific involvement of caveolin in this response.
Little is known about the spatial-temporal organization of AT 1 R-related signaling components within the cell membrane and the mechanisms by which signaling specificity is achieved. The compartmentalization of signaling molecules is likely required to provide the suitable molecular proximity necessary for rapid, efficient, and specific activation of downstream signaling events. We have previously shown that Ang II stimulates movement of AT 1 Rs into a caveolin-enriched membrane fraction and induces association of caveolin and AT 1 Rs in VSMCs (5); however, the role of this microdomain in Ang II signaling has not been elucidated. Because caveolae are enriched in cholesterol, cholesterol-binding agents have been used to disrupt caveolae structure and interfere with their functionality (24 -26) . In the present study, we demonstrated that cholesterol depletion of the plasma membrane by ␤-cyclodextrin, which almost completely disrupted caveolae structure (Fig. 1) , significantly inhibited Ang II-induced phosphorylation of EGF-R. Similar inhibitory effects were observed by other cholesterol binding drugs, filipin and nystatin ( Fig. 2A) . In contrast, EGF-R autophosphorylation induced by EGF was enhanced by ␤-cyclodextrin treatment (Fig. 2B) , implying that it is the transactivation process that requires intact cholesterolrich microdomains in VSMCs. Importantly, cholesterol-loaded ␤-cyclodextrin did not inhibit Ang II-induced EGF-R phosphorylation, supporting the conclusion that the inhibitory effects of ␤-cyclodextrin on Ang II signaling are due to its ability to bind cholesterol. As a consequence, cholesterol depletion by ␤-cyclodextrin significantly attenuated Ang II-, but not EGF-, induced activation of Akt/PKB, which is a downstream target of EGF-R (1). Consistent with our present results, reduction of plasma membrane cholesterol levels with cholesterol-binding agents has been shown to inhibit specific agonist-stimulated signaling pathways (e.g. insulin-stimulated IRS1 phosphorylation (7) and shear stress (9), nerve growth factor (10), and endothelin-1 (8)-induced activation of ERK), which correlated with disruption of caveolae structure. Thus, these results strongly suggest that cholesterol-enriched membrane microdomains are critically important for transactivation of EGF-Rs by Ang II in VSMCs.
Several signaling mechanisms have been implicated in Ang II-induced EGF-R transactivation, including calcium and c-Src in VSMCs (2, 19) . Interestingly, cholesterol depletion had no effect on either of these early signaling events, suggesting that the intact cholesterol-enriched microdomain is not required for the initial activation of calcium and c-Src. The fact that the Ang II-induced Ca 2ϩ transient is cholesterol-independent is supported by our previous observation that the initial, phasic phospholipase C signal associated with Ca 2ϩ mobilization does not require the sequestration/internalization of AT 1 Rs (3). Previously, we demonstrated that Ang II induces AT 1 R movement into the caveolin-enriched fraction in VSMCs (5) . The initial phase of signaling may occur in non-caveolin-containing signaling compartments and non-cholesterol-enriched lipid rafts (28) . The differential effects of cholesterol depletion on Ang II-stimulation of EGF-R phosphorylation and its upstream signaling pathways indicate that transactivation of EGF-Rs specifically requires physical compartmentalization of signaling molecules in cholesterol-rich structures.
One of the major signature proteins of caveolae is caveolin. The function of caveolae and caveolae-related signaling events is regulated by caveolin, at least in part through its scaffolding function (4) . Caveolin can interact directly with the EGF-R and retain it in an inactive state in caveolae, so that the EGF-R is immediately available for stimulation (4, 21) . Based on these observations, we predicted that for Ang II to transactivate the EGF-R, the EGF-R would first have to dissociate from caveolin. This is in fact what we found. The EGF-R coimmunoprecipitates with caveolin in resting cells, and upon stimulation with Ang II, activated EGF-R dissociates from caveolin, possibly as it becomes associated with focal adhesions (Figs. 4 and 5) . Importantly, only ϳ6% of EGF-Rs coimmunoprecipitate with caveolin, suggesting that EGF-Rs exist in multiple subcellular domains, as has been shown in fibroblasts (29) . Our data are consistent with the concept that it is the caveolin-associated EGF-Rs that become a target for transactivation of EGF-R in Ang II-signaling. Previous work has shown that a conserved region of the tyrosine kinase domain of the EGF-R interacts with the scaffolding domain of caveolin (21) . Although the mechanisms by which caveolin inhibits EGF-R kinase activity are unknown, it has been speculated that caveolin binding may stabilize the receptor kinase in an inactive conformation or prevent receptor dimerization and subsequent transphosphorylation as a consequence of steric hindrance (21) . This interpretation is supported by our present observation that EGFinduced autophosphorylation of the EGF-R is significantly enhanced by the cholesterol depletion by ␤-cyclodextrin (Fig.  2B) . Thus, Ang II-stimulated dissociation of EGF-Rs from caveolin may be an essential step in transactivation of EGF-Rs in VSMCs.
Of importance, the time course of EGF-R-caveolin dissociation is cotemporaneous with that which we have observed for c-Src activation (30) and for c-Src-dependent tyrosine phosphorylation of caveolin (Fig. 4B) . Caveolin-1 was originally identified as a major tyrosine-phosphorylated protein in v-Src-transformed chicken embryo fibroblasts (11) . Although the functional significance of Src-dependent tyrosine phosphorylation of caveolin-1 is unknown, phosphocaveolin may provide a docking site for SH2-containing molecules (12) . Interestingly, EGF-Rs phosphorylated on the c-Src-specific phosphorylation site co-localize with vinculin and tyrosine-phosphorylated caveolin after Ang II stimulation, and this pattern appears to be compartmentalized in focal adhesions (Fig. 5) . Of note, the bulk of total caveolin is not localized in focal adhesions, suggesting that only a subfraction of caveolin is tyrosine-phosphorylated. This is consistent with our present immunoprecipitation results showing that ϳ8% of total caveolin is tyrosinephosphorylated after stimulation with Ang II. The intense localization of tyrosine-phosphorylated caveolin-1, but not total caveolin-1, in focal adhesions has been previously demonstrated in NIH3T3 and A431 cells stimulated with insulin and EGF (12) .
These data suggest that the focal adhesion may be another important signaling domain that facilitates assembly of active signaling complexes. Indeed, disruption of the actin cytoskeleton and its associated focal adhesions with cytochalasin D completely inhibits Ang II-, but not EGF-, induced EGF-R phosphorylation. 2 This result supports the concept that an intact cytoskeleton and/or focal adhesions are required for Ang II-induced transactivation of the EGF-R, in VSMCs. The colocalization of activated EGF-Rs, paxillin and tyrosine-phosphorylated caveolin suggests that in focal adhesions, phosphorylated caveolin may function as a positive regulator for transactivation and may be relevant to the generation of active, spatially organized signaling molecules. Indeed, phosphorylation of caveolin at tyrosine 14 has been suggested to provide a docking site for SH2-domain-containing proteins such as Grb-7 (12), an adapter protein that binds to EGF-Rs (31, 32) . Ang II stimulation of VSMCs may thus promote translocation of EGF-Rs from caveolae/caveolin in unstimulated cells to other signaling domains such as focal adhesions, the major sites of tyrosine kinase signaling in vivo, which are then responsible for EGF-R transactivation. The mechanism of communication between cholesterol-rich domains such as caveolae and lipid rafts, which harbor the initial, inactive signaling complexes, and focal adhesions that organize active signaling complexes is unclear. It is possible that these two compartments may interact physically via actin-binding proteins or via GTP-binding proteins such as RhoA, which are found in caveolae-enriched membrane domains as well as focal adhesions (27, 33) . The exact temporal and spatial relationships between cholesterolrich microdomains and focal adhesions in activation of Ang II signaling will require further investigation.
In summary, the present study demonstrates that cholesterol-enriched membrane microdomains are involved in EGF-R transactivation by Ang II in VSMCs. The involvement of caveolin in transactivation reported here suggests a specific role of caveolae in this process. The EGF-R initially binds caveolin, but this association is rapidly disrupted by Ang II stimulation. Transactivated EGF-Rs localize in focal adhesions together with tyrosine-phosphorylated caveolin. Thus, focal adhesions also participate in EGF-R transactivation by Ang II. Dynamic changes in association of caveolin with EGF-Rs (the present study) and AT 1 Rs (5) and their specific membrane localization may facilitate the cross-talk between AT 1 R and EGF-R signaling pathways. These findings suggest that the scaffolding role of caveolin is essential for the EGF-R transactivation by Ang II and that cholesterol-rich microdomains as well as focal adhesions are important signal-organizing compartments required for the spatial and temporal organization of AT 1 R signaling in VSMCs.
